Humana (NYSE:HUM) PT Lowered to $250.00 at Barclays

Humana (NYSE:HUM) had its price objective trimmed by Barclays from $364.00 to $250.00 in a research note published on Thursday, Benzinga reports. The firm currently has an equal weight rating on the insurance provider’s stock.

Several other equities research analysts also recently issued reports on the company. TD Cowen downgraded Humana from a buy rating to a hold rating and lowered their price target for the stock from $402.00 to $261.00 in a report on Monday, October 7th. Jefferies Financial Group downgraded shares of Humana from a buy rating to a hold rating and dropped their target price for the stock from $519.00 to $253.00 in a report on Monday, October 7th. UBS Group cut their price target on shares of Humana from $380.00 to $250.00 and set a neutral rating on the stock in a research note on Friday, October 4th. Leerink Partners downgraded shares of Humana from an outperform rating to a market perform rating and lowered their price objective for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Finally, Royal Bank of Canada cut their price objective on shares of Humana from $400.00 to $265.00 and set an outperform rating on the stock in a research report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Humana presently has an average rating of Hold and a consensus target price of $315.33.

Humana Price Performance

Humana stock opened at $258.07 on Thursday. The firm has a market capitalization of $31.10 billion, a P/E ratio of 16.07, a PEG ratio of 1.91 and a beta of 0.50. The business has a 50-day moving average of $324.76 and a 200-day moving average of $340.20. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana has a 1 year low of $213.31 and a 1 year high of $530.54.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $8.94 earnings per share. On average, equities analysts anticipate that Humana will post 16.06 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be paid a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.37%. Humana’s dividend payout ratio is 22.04%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Heritage Oak Wealth Advisors LLC acquired a new stake in Humana during the 2nd quarter valued at $3,456,000. APG Asset Management US Inc. raised its holdings in Humana by 3.0% in the 2nd quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock valued at $25,274,000 after acquiring an additional 1,955 shares during the period. Sei Investments Co. lifted its position in Humana by 0.4% during the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after acquiring an additional 264 shares during the last quarter. Cetera Advisors LLC boosted its holdings in shares of Humana by 472.1% during the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after acquiring an additional 8,333 shares during the period. Finally, Northwestern Mutual Wealth Management Co. grew its position in shares of Humana by 113.4% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,619 shares of the insurance provider’s stock valued at $2,099,000 after purchasing an additional 2,986 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.